Moreover, bone marrow stromal cells in MDS and AML patients have been shown to secrete IGF ligands, further supporting a paracrine loop that promotes leukemic cell survival and chemoresistance (15). This evidence concerns the gene IGF1 and myelodysplastic syndrome.